Georgia Erbez
CIK 1557930 · See Remarks · last filed 2026-10-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HARP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
FREMONT, CA 94555
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDXS | See Remarks | 60,475 | $1.31 | $79.2K | -$29.2K | 6 | 2026-10-14 |
| CHRS | Director | — | $1.05 | — | $0 | 3 | 2025-06-13 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | — | $54.99 | — | $0 | 2 | 2022-07-01 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | Chief Financial Officer | 9,151 | $23.01 | $210.6K | $279.0K | 10 | 2022-02-01 |
| ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Director | — | $0.01 | — | $0 | 1 | 2019-08-30 |
| Zosano Pharma Corp (ZSAN) Delisted | CFO and Chief Business Officer | 165 | $0.56 | $92 | $152.8K | 3 | 2017-05-25 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Exec VP & CFO | — | — | — | $0 | 1 | 2015-11-12 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Chief Financial Officer | 2,500 | — | — | -$99.3K | 3 | 2014-02-11 |
Recent Filings · Page 3 of 4
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-04 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-23 | Harpoon Therapeutics, Inc. (HARP) Delisted | Buy (P) | +6,700 | $94.4K | EDGAR |
| 2019-12-06 | Harpoon Therapeutics, Inc. (HARP) Delisted | Exer (M) | +47,292 | $100.3K | EDGAR |
| 2019-08-30 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-25 | Zosano Pharma Corp (ZSAN) Delisted | Buy (P) | +68,000 | $89.8K | EDGAR |
| 2016-09-09 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-22 | Zosano Pharma Corp (ZSAN) Delisted | Buy (P) | +47,750 | $63.0K | EDGAR |
| 2015-11-12 | Asterias Biotherapeutics, Inc. (AST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-11 | Raptor Pharmaceutical Corp (RPTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-09-03 | Raptor Pharmaceutical Corp (RPTP) Delisted | Sell (S) | −7,400 | -$99.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.